Most artificial cannabinoids are agonists on the cannabinoid receptors. They are already intended to be similar to THC,[nine] the all-natural cannabinoid with the strongest binding affinity towards the CB1 receptor, and that is connected to the psychoactive outcomes or "high" of cannabis.[10] These synthetic analogs frequently have increased bindin